You are here

AbbVie

Skyrizi notches top pharma, Rx brand spot for Q3 2024

Medical Marketing and Media

Mon, 10/7/24 - 09:52 pm

Crohn's Disease

psoriatic arthritis

AbbVie cuts 2024 profit forecast citing R&D expenses

Reuters

Thu, 10/3/24 - 09:26 pm

Louisiana district court upholds state 340B contract pharmacy law

American Hospital Association

Wed, 10/2/24 - 10:01 pm

contract pharmacies

EU withdraws marketing authorisation for Abbvie's hepatitis C drug

Reuters

Wed, 10/2/24 - 11:16 am

Blue Shield of California bypasses PBMs to slash Humira prices by 90%

Pharmaphorum

Wed, 10/2/24 - 09:37 am

AbbVie seeks FDA approval for non-small cell lung cancer treatment

Pharmaceutical Business Review

Mon, 09/30/24 - 09:45 am

non-small cell lung cancer

AbbVie’s $8.7bn Parkinson’s disease drug shines in Phase III trial

Clinical Trials Arena

Mon, 09/30/24 - 09:15 am

Parkinson's Disease

clinical trials

AbbVie's Parkinson's disease drug meets main goal in late-stage trial

Reuters

Thu, 09/26/24 - 11:21 am

Parkinson's Disease

clinical trials

AbbVie’s RINVOQ shows promise in two Phase III atopic dermatitis trials

Clinical Trials Arena

Thu, 09/26/24 - 11:14 am

atopic dermatitis

clinical trials

New migraine drugs less effective than previous generation of triptan meds: BMJ study

Fierce Pharma

Thu, 09/19/24 - 09:29 pm

UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year

AOL

Tue, 09/10/24 - 04:33 pm

Unitedhealth Group

AbbVie sues rival BeiGene over alleged theft of cancer therapy secrets

Reuters

Tue, 09/10/24 - 09:15 am

AbbVie's Ubrelvy wards off migraines when used in reaction to early warning signs: study

Fierce Pharma

Thu, 08/29/24 - 06:06 pm

clinical trials

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year

Reuters

Mon, 08/26/24 - 10:14 pm

BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings

Pharma Voice

Mon, 08/19/24 - 09:58 am

Bristol Myers Squibb

Skyrizi soars to top of Rx, OTC pharma brand rankings in July

Medical Marketing and Media

Tue, 08/13/24 - 11:25 am

Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth

Fierce Pharma

Fri, 08/9/24 - 11:25 am

Pharma execs react to final drug price negotiations with Medicare

Pharma Voice

Fri, 08/9/24 - 11:21 am

Inflation Reduction Act

Bristol Myers Squibb

Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half

Pharma Voice

Thu, 08/8/24 - 11:07 am

Big Pharma-Backed Ribon Therapeutics Shuts Down Business Operations

BioSpace

Mon, 08/5/24 - 11:21 am

Ribon Therapeutics

PARP inhibitors

Pages